Suppr超能文献

[格雷夫斯-巴塞多氏病合并进行性浸润性眼病患者在接受糖皮质激素和眶后组织照射治疗期间抗甲状腺膜抗原抗体的滴度]

[Titers of antibodies against thyroid membrane antigens in patients with Graves-Basedow disease and progressive infiltrative ophthalmopathy during treatment with glucocorticoids and retro-orbital tissue irradiation].

作者信息

Pilarska K, Syrenicz A, Czekalski S, Gołebiowska I, Andrzejewska W, Krzystolik Z

机构信息

Kliniki Endokrynologii i Chorób Przemiany Materii.

出版信息

Pol Tyg Lek. 1991;46(43-44):824-6.

PMID:1669170
Abstract

In 22 patients with progressive endocrine ophthalmopathy (classes 4-6 according to Werner's scale and ophthalmopathy index at least 4 and evidences of infiltrative changes in retro-ocular tissues in computerised tomography, after achievement of euthyroid state) the titers of antibodies against thyroid membrane antigens (ATMA) were determined by Gardas and all. method. Control group consisted of 26 patients with Graves-Basedow disease without clinical signs of ophthalmopathy who were investigated for ATMA before and after conventional methimazole treatment. The determinations of ATMA were performed before treatment, after 3-4 weeks and subsequently once a month. ATMA's titers exceeding 1:1000 were found in 68% of patients with progressive infiltrative ophthalmopathy and in 77% of patients with Graves-Basedow disease without ophthalmopathy. The incidence of elevated ATMA titers during treatment of ophthalmopathy with supervoltage retro-orbital tissues irradiation with high dose of prednisone, decreased markedly in 6th month of treatment with subsequent increase to average 55% at the end of treatment what suggests the influence of therapy on antibodies production. The changes in the incidence of elevated ATMA titers during conventional Graves-Basedow disease treatment were different. No relations between increased ATMA titers and intensity of infiltrative ophthalmopathy and the course of treatment in the patients with ophthalmopathy were found.

摘要

在22例患有进行性内分泌性眼病的患者中(根据Werner分级为4 - 6级,眼病指数至少为4,且计算机断层扫描显示眼后组织有浸润性改变,处于甲状腺功能正常状态后),采用Gardas等人的方法测定抗甲状腺膜抗原(ATMA)抗体滴度。对照组由26例无眼病临床体征的Graves病患者组成,在常规甲巯咪唑治疗前后检测ATMA。在治疗前、3 - 4周后以及随后每月测定一次ATMA。在68%的进行性浸润性眼病患者和77%无眼病的Graves病患者中发现ATMA滴度超过1:1000。在用高剂量泼尼松进行超电压眶后组织照射治疗眼病期间,ATMA滴度升高的发生率在治疗第6个月时显著下降,随后在治疗结束时平均升至55%,这表明治疗对抗体产生有影响。在常规Graves病治疗期间,ATMA滴度升高的发生率变化不同。在患有眼病的患者中,未发现ATMA滴度升高与浸润性眼病的严重程度以及治疗过程之间存在关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验